KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Bristol Myers Squibb (BMY) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to $0.54.

  • Bristol Myers Squibb's EPS (Basic) rose 125000.0% to $0.54 in Q4 2025 from the same period last year, while for Dec 2025 it was $3.47, marking a year-over-year increase of 17850.68%. This contributed to the annual value of $3.47 for FY2025, which is 17868.48% up from last year.
  • Per Bristol Myers Squibb's latest filing, its EPS (Basic) stood at $0.54 for Q4 2025, which was up 125000.0% from $1.08 recorded in Q3 2025.
  • Over the past 5 years, Bristol Myers Squibb's EPS (Basic) peaked at $1.21 during Q1 2025, and registered a low of -$5.89 during Q1 2024.
  • For the 5-year period, Bristol Myers Squibb's EPS (Basic) averaged around $0.45, with its median value being $0.79 (2024).
  • As far as peak fluctuations go, Bristol Myers Squibb's EPS (Basic) skyrocketed by 127500.0% in 2021, and later crashed by 64537.04% in 2024.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's EPS (Basic) stood at $1.07 in 2021, then decreased by 10.28% to $0.96 in 2022, then fell by 9.38% to $0.87 in 2023, then plummeted by 95.4% to $0.04 in 2024, then surged by 1250.0% to $0.54 in 2025.
  • Its last three reported values are $0.54 in Q4 2025, $1.08 for Q3 2025, and $0.64 during Q2 2025.